10 Best Day Trading Stocks To Invest In Now

Page 7 of 10

4. Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO)

Number of Hedge Fund Holders: 4  

Beta as of February 25: 3.54

Share Price Increase Over Last Month as of February 25: 15%

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) develops and commercializes epigenetics-based clinical tests for cardiovascular disease. In the third quarter of 2024, the net loss narrowed by 27% year-over-year to $1.41 million. On February 4, the company partnered with seven new provider organizations. This expansion reflects the increasing adoption of its advanced blood tests, Epi+Gen CHD and PrecisionCHD, aimed at improving coronary heart disease prevention, detection, and management. The addition of these new provider partners underscores the growing adoption of Cardio Diagnostics’ solutions across a wide variety of clinical settings.

Page 7 of 10